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INTRODUCTION 
 
Gastroesophageal Reflux disease (GERD) is a condition that arises 
from reflux of  gastric contents into the  esophagus through the  lower 
esophageal  sphincter  causing  symptoms  and/or  injury to esophageal or  
extraesophageal structures. While  normal people  may experience reflux  
symptoms once in a while, say  for  example  after a heavy meal these are  
usually  infrequent  and  do not  interefere  with  patients  quality of  life  
nor  do they  cause significant  esophageal  injury. Pathological reflux  
occurs  when the esophageal  defense  mechanisms including  acid 
clearance  and  mucosal resistance  are overwhelmed  by the  injurious  
refluxate such as acid, pepsin, bile, duodenal contents. Lower Esophageal 
Sphincter(LES)  is the  most  important  component  of  antireflux  barrier  
and  is  a tonically  contracted  smooth muscle  of  length 3-4cm  located  
at the gastroesophageal  junction. Resting LES pressure  varies between 
10-30 mm Hg  and its reserve is high since even a pressure of 5-10mmHg 
can prevent reflux. Resting  tone of  LES  is a function of both myogenic  
and neurogenic components. Acetyl choline  released  from muscarinic  
system  is the  predominant  neurotransmitter  in maintaining  resting  
LES tone. In  addition the diaphragmatic contractions  augment LES 
pressure  during  inspiration. LES  is designed  naturally to prevent  
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reflux  while  at the  same time  it  provides  air venting  through belching  
mechanism  by relaxing  transiently, especially  postprandially, called   as 
TLOSRs-Transient  Lower esophageal   Sphincter Relaxations. But, this  
natural mechanism  of belch which when severe   and  frequent causes 
pathological reflux. TLOSRs  are  the predominant  cause  of   GERD in 
most  cases  of  GERD   while  in 20%  cases  LES incompetence  is the  
causative  factor. According  to the MONTREAL Definition1, gastro 
esophageal  reflux disease is a condition which develops when the reflux 
of gastric contents causes  troublesome symptoms and/or  complications. 
The  characteristic  symptoms of  GERD  include retrosternal  burning  
sensation  and regurgitation which  is defined as  perception  of  flow  of  
refluxed gastric  content  into mouth  or  hypopharynx. GERD  related  
disease manifestations  are further classified as esophageal and 
extraesophageal  syndromes. 
Esophageal syndromes include syndromes which are  typically  not  
associated  with  esophageal  injury  such  as  typical  reflux  syndrome, 
reflux chest pain syndrome  and  syndromes  associated  with  esophageal 
injury such as endoscopic  esophagitis, esophageal strictures, barretts 
metaplasia, adenocarcinoma. extraesophageal syndromes with   
established  associations include  reflux cough syndrome, laryngitis, 
asthma, Dental erosions.  
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Diagnosis of   GERD  may  be  accompalished  by different 
methods including symptomatic criteria, endoscopic  criteria, Biopsy  
criteria, ambulatory  pH Monitoring  criteria. The  typical reflux  disease  
is symptomatically defined and it does not  require  diagnostic  testing2. 
An empirical  trial of  acid suppression is the most definitive  test  to 
diagnose  GERD  and   assess  its relation to symptoms. Symptoms  
usually respond  to trial of  PPI  in  one to two weeks. Reflux esophagitis 
is the  term used to encompass  endoscopically  demonstrable  esophageal  
mucosal  breaks, erosions and also  normal  endoscopic appearances  but 
histological  evidence  of  dilated  intercellular  channels  usually 
demonstrable  with electron microscopy3 Absence  of   visible  erosions is 
noted  in over 50%   of  patients  presenting. With  typical reflux  
symptoms4 Reflux esophagitis is  diagnosed  by   endoscopy when  
visible breaks  are noted in esophageal mucosa at  or above 
gastroesophageal junction.Various  classification systems  have  been  
published To  assess  severity  of   endoscopic  esophagitis  but   the  Los  
Angeles  Classification  System  has gained  general  acceptance. 5 
Ambulatory pH monitoring  is  a standard test  to establish  pathologic 
reflux and reflux  episodes  are  defined  by  pH  drop  less than 4. 
Not all cases of  GERD  present  with typical  symptoms  and there  
exists a subset of   cases  who may  present  with  additional  symptoms  
of  nausea, early satiety and postprandial fullness. This subset  may  
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represent  an overlap syndrome  with  functional  dyspepsia  and  account  
for 30%  of  GERD cases which is a significant  proportion6. Gastric  
emptying of chyme is the most important mechanical function of 
stomach. Studies have demonstrated that a quarter of  patients with  
GERD  demonstrate  delayed  gastric  emptying 7 Prior  studies  of  gastric 
emptying assessment  in GERD  have  included specific  risk  factors   for 
gastroparesis such as diabetes  mellitus and therefore  have  spuriously  
high  prevalence  of  gastroparesis in GERD cases. Exclusion of  specific 
risk  factors of gastroparesis  is therefore important  to identify   
idiopathic gastroparesis  in  GERD cases.  
The pathophysiological relationship between GERD and 
gastroparesis is  multifactorial and bidirectional i.e one may affect another 
by multiple mechanisms. tLOSRs may contribute to delayed GE8. GERD 
patents also tend to retain  solids in  proximal stomach more  than  
controls and this may stimulate additional tLOSRs9. Gastric  emptying 
can be assessed  by  number  of   methods  including  scintigraphy, MRI, 
functional USG. Tests such as MRI are  evolving and it does not  provide  
direct  assessment of meal  emptying since the volume of gastric contents 
has to be  corrected  for  gastric secretions which dilute the meal10 
Functional  ultrasonography  is best suited for  assessment of  liquid 
phase emptying  which is of  limited  clinical utility since it does not  
become abnormal till  gastroparesis is severe11. 
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Gastric  scintigraphy  with solid phase  labeling  is   considered  to 
be  the gold standard  test  for  assessment  of   gastric  emptying  since it  
provides  visual  assessment  of gastric emptying  and has been used  in 
number  of studies. Scintigraphy  not only  provides  global   GE values   
but also assesses  retention of  food in  antrum   versus  fundus, thus  
providing regional GE values which may help understand  
pathophysiological  correlation  between  gastroparesis  and   propensity 
for  reflux. This is important to know since PPIs do not address  gastric 
neuromuscular dysfunction. Thus it may help decide  choice  of treatment  
such as additional role  for  prokinetics, fundic  relaxants  such  as  
acotiamide, surgical management any of which need to be considered 
since PPI alone may not control  symptoms gastroparesis in this sub set of 
overlap cases. Objective measurement of  gastric emptying can be 
coupled  with  symptom profile  assessment after ingestion of  test meal 
to find if  any symptomatic correlation exists. This study titled 
“Gastroparesis in gastroesophageal reflux disease - prevalence and 
assessment using  gastric  scintigraphy  with symptomatic correlation” is 
a prospective  study  conducted  in the  Department of Medical 
Gastroenterology, Rajiv Gandhi Government General Hospital, Madras 
Medical College and  Advanced Nuclear Medicine Research Centre, 
Chennai. 
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AIM 
 
To  study  the  prevalence  of  gastroparesis in GERD patients and 
assessment of the same  by gastric  scintigraphy and correlate  it with  
gastroparesis  cardinal symptom index. 
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REVIEW OF LITERATURE 
 
GERD AND FUNCTIONAL DYSPEPSIA 
Gastroesophageal reflux disease  and  functional dyspepsia are two 
common upper gastrointestinal disorders  encountered  in  clinical 
practice. GERD is defined by montreal definition  as a condition  which 
develops when reflux of gastric contents causes troublesome symptoms 
and /or  complications. Heart burn and regurgitation represent  two of 
characteristic  symptom 
                 
 
FIGURE 1:   MONTREAL  DEFINITION  OF  GERD1 
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Functional dyspepsia  on the other hand is defined by  Rome  III 
criteria  as  presence of symptoms thought to originate  in gastroduodenal 
region which include nausea/vomiting, postprandial fullness or  early 
satiety, abdominal  bloating. It also classifies  FD into two distinct  
entities  namely  the  epigastric pain syndrome   and  postprandial distress 
syndrome. Although GERD and FD appear  distinct based on definitions, 
there is a significant overlap noted in epidemiology, pathophysiology, 
genetics, symptomatic presentation, diagnostic  and therapeutic aspects of  
these  two diseases. 
EPIDEMIOLOGICAL OVERLAP  - INDIAN SCENARIO 
Traditionally GERD is thought to be  a disease  of  western world 
where  prevalence  of 10-20% have been reported. In India prevalence  
rates were thought to be low (<5%) but recent  studies which enrolled  
large number of  cases in urban and rural populations have  shown that  
prevalence rates of GERD varies between 7.6 percent12 to 18.7 percent13 
indicating prevalence trends similar to the west. This could be attributed  
to socioeconomic development, adoption  of  western diet, epidemic of 
obesity and reduction in H pylori prevalence. World wide  prevalence of  
FD is around 20-30%14 whereas  the minimal Indian literature  on FD 
gives a prevalence  range of 7.5 %15 to 49%.16 Thus we can see clearly 
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that there is significant  epidemiological overlap of  these two conditions 
in India. 
PATHOPHYSIOLOGICAL  OVERLAP 
GERD has traditionally been  classified  as  Erosive Reflux disease 
(ERD), Non  erosive  reflux disease (NERD) and complicated  disease 
which includes barretts metaplasia, adenocarcinoma, strictures. NERD  
has been  classified into 3 subtypes based on 24h ambulatory pH 
monitoring  studies17 
TABLE 1 : NERD SUBGROUPS 
NERD subgroups Type 1 
Type 2 
The “sensitive” 
esophagus 
Type 3 
Functional 
heartburn 
Acid exposure time Abnormal Normal Normal 
Symptom–reflux 
correlation 
Positive Positive Negative 
Response to acid 
suppression 
Yes Yes None 
 
The likelihood of  overlap  between the  two disorders is  greater in  
patients with  NERD than  ERD. Even within the subtypes of NERD, 
overlap of FD is greatest  among  patients  with  functional heartburn18 An 
overlap between  GERD and  FD would certainly  be expected on the 
basis of  interrelated  physiology  of  lower esophageal  sphincter  and  
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gastric fundus. Gastric fundus is intimately involved in triggering  
tLOSRs which are  fundamental  to GERD.19  
A  study  of  overlap cases  classified  patients  into 3 categories 
including GERD  alone, FD alone, GERD with FD.20 It assessed regional 
and global gastric emptying in each category. Gastric emptying was 
found to be delayed in 50%  cases in each category.  Fundal retention of  
food  was noted in GERD cases and antral retention of  food noted  in 
overlap cohorts. Gastric dysmotility may explain relative  ineffectiveness 
of PPI therapy  in  patients  with overlap   cases  and also why  
prokinetics may  help in such cases21 
GENETIC  OVERLAP 
G protein Coupled  Receptors are  involved  in signal  transduction. 
Altered  function  of  GPCRs  are noted to be associated with depression  
in Functional dyspepsia cases, especially the  GNB3 subunit polymorphism 
(C825 T). Three genotypes  can arise  out  of this  polymorphism 
including TT,CT, CC genotypes.CC genotype is associated  with  reduced  
levels  of  the beta 3 splice variant resulting  in impaired GPCR  signal 
transduction. This  CC Genotype  has been  found to be associated with 
FD symptoms22 The authors postulate  that  reduced  intracellular  signal 
transduction can result in dysregulation of  antinociceptive pathway and 
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thus link it to abdominal  pain in FD. Studies  have  also evaluated  
GPCR polymorphisms in GERD cases. The reason for  evaluation being 
that GPCRs mediate  response  to acid and  modulate  esophageal  
sensory  function.GERD  has been shown to be associated with  GNB3 
C825 T Polymorphism.23 
SYMPTOMATIC  OVERLAP 
Heart burn and regurgitation  are the  cardinal  symptoms  of  
GERD whereas  epigastric  discomfort  which includes  burning, pressure  
or fullness with or without  abdominal  bloating,early satiety  characterize  
FD and symptoms may be  postprandial. Thus epigastric burning 
discomfort  may  be misunderstood  as retrosternal discomfort  creating  
dilemma. Also symptoms of GERD and FD may coexist in true overlap 
cases. 
DIAGNOSTIC TESTING-OVERLAP 
24h pH  monitoring 
A  prospective  study  of  247 FD  patients  showed  that 23 %  of 
cases had  abnormal  24 h pH study  defined by  acid exposure  more than  
5% of time. Interestingly these patients did not report GERD Symptoms24 
This study  highlights  diagnostic  overlap of   FD with GERD.  Gastric  
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emptying  studies Gastric emptying  is delayed  in 30%  of cases  of  FD25 
Delayed gastric emptying especially of proximal stomach may  promote  
reflux of gastric contents  resulting  in GERD, thus  creating  a scenario 
for overlap. Thus gold standard  tests for diagnosis of GERD and FD, 
namely  24h pH study  and  gastric  emptying  studies may  not  be clearly  
delineate specific  disorders  due to propensity  for  overlap noted  
between these  two conditions. 
THERAPEUTIC  OVERLAP 
PPI (Proton Pump Inhibitor) 
Both  GERD  and  FD  are  currently managed  with  PPIs. While  
PPIs are  considered  the  standard  of  care  in GERD, several studies  
have shown that  PPIs have  either  no benefit26 or only  modest benefit27 
in patients with  FD.A metaanalysis of  7  randomized  control trials  of  
PPI  in FD patients (n=3725)  showed a significant  benefit  with  PPI  use  
compared  to placebo.28 In  general it is agreed that FD patients with 
reflux related  symptoms benefit from  PPI therapy  than those without  it. 
PROKINETICS 
Theoretically,  prokinetics seem a good choice  for  management of 
GERD since these drugs  act  by increasing  resting  LES Pressure   and  
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by  accelerating gastric emptying. This effect  is illustrated   by  cisapride 
(mixed 5HT4 Agonist  and  5HT3 Antagonist) ,the best  studied 
prokinetic agent in GERD. However the potential  to cause  QT  
prolongation and cardiac  arrhythmias led to its  withdrawal  from market. 
Prokinetics in general  have  limited role in  management  of   GERD  due 
in part  to  the  side  effect  profile  of the drugs available. 
A variety  of  prokinetics have been  tried  in  FD cases. Tegaserod,  
the first  agent  tried  showed  only  marginal  benefit  in  FD cases29 but 
cardiac  side effects limit its use.Phase  III  trials  of  itopride  did not  
show  any  benefit  over  placebo in  FD cases30 
FUNCTIONAL  ORGANIZATION  OF  GASTRIC  MOTILITY 
OVERVIEW 
The  Stomach  is  a  hollow organ  functionally  separable  as 
proximal  and  distal  portions, with  presence  of  sphincters  at  both  
ends.31 This  arrangement  reminds   one  of  cardiac  chambers especially  
the  cardiac  valves   and  the ventricles proper  which have  an inlet  
portion  to  receive blood  from the atria  and an outflow  portion which  
pumps  blood  into the  great vessels, to allow oxygenation and  delivery   
of blood to every  tissue  in our body. Also, both the organs have  a 
pacemaker  indicating  how  gastric  emptying  and  cardiac  ejection are   
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functionally similar. Proximal portion of  stomach  is functionally  
distinct  from distal  portion and this separation  allows  for  efficient  
functioning  of   stomach. 
COMPONENTS  OF  GASTRIC MOTILITY 
GASTRIC  PACEMAKER   AND  ORIGIN  OF  SLOW  WAVES 
At  the  cellular  level , the most  important  structure  is  the 
smooth  muscle cell with  the ICC-Interstitial  cells of  Cajal  being  
specialized  form. The  characteristics  of  smooth  muscle  cells of  
proximal  stomach vary  from those  located  in distal  stomach. Proximal 
stomach smooth muscle cells generate  tonic contractile activity  whereas  
distal stomach  smooth muscle Cells generate  phasic  contractile  
activity. The  rhythmic electrical  activity Responsible  for  phasic  
contractions  of  antrum  is   called   as  Slow waves. 
The  Slow waves  have  their  origin  from  interstitial  cells  of  
Cajal,  located  In the gastric  pacemaker in the  greater  curvature  in 
region of   corpus. Slow Waves  are nothing  but  oscillations   in  
membrane  potential occurring at  Rate  of  3 cycles per  minute(cpm)  
with  action potential  peaks in between  determining  both the frequency   
and  strength  of   gastric contractions. 
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FIGURE 2: GASTRIC  ELECTRICAL  ACTIVITY 
 
MYENTERIC  PLEXUS 
Gastric  wall  comprises  the  inner  circular   and outer longitudinal 
muscle layers, with  the  myenteric  plexus  sandwiched  in between. This  
plexus, although  receiving  inputs  from  extrinsic  nervous  system, 
including vagus and sympathetics, is characterized  by its functional  
autonomy.  
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FIGURE 3:  MYENTERIC  PLEXUS 
 
EXTRINSIC  INNERVATION  OF   STOMACH 
PARASYMPATHETIC  SUPPLY 
 
Derived    from vagus.90%  of  innervation is  sensory and  only  
10% Is  motor. The Sensory  innervation is  carried  via  nucleus  tractus 
solitarius to the  brainstem  and  the  vagal  efferents originate  from 
dorsal   motor  nucleus  to complete  this  vagovagal  pathway  which has  
important  role  in  regulating  gastric  motility. 
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SYMPATHETIC  SUPPLY  
Derived from spinal  segments T6-T9. This system acts as negative  
regulator  of  motility of stomach  via inhibition   of presynaptic release 
of acetylcholine  from  myenteric  plexus. 
FASTING  STATE  VERSUS  FED  STATE  GASTRIC  ACTIVITY 
IS  STOMACH  QUIESCENT IN FASTING  STATE? 
In fasting  state,stomach  and  small intestine  demonstrate  cyclical 
motor activity  called  as  Migrating  Motor  Complex (MMC) which  has 
three  specific  phases spread  over  90-120 min. 
Phase  I 
Consists   of  no  demonstrable  contractile  activity. 
Phase  II 
Consists   of   irregular  contractions. 
Phase III 
Consists  of   regular  contractions. 
Phase  III  of   MMC  occurs  at  a  rate  of  3 cpm in stomach  and  
12 cpm In duodenum. It  migrates  along length  of gut  at  rate of  1-4cm 
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per minute. Phase III of MMC is responsible for clearance of indigestible 
food residue from stomach and  proximal intestine. 
FED STATE 
GASTRIC  HANDLING  OF SOLID MEAL 
PROXIMAL STOMACH –RESERVOIR FUNCTION 
In the  fasting state, gastric fundus exhibits tonic contraction  called 
as  fundic tone and  is  mediated  by vagovagal  pathway. But, as the food 
descends from esophagus into proximal stomach, two temporally  spaced  
events  occur. 
1.  Receptive relaxation 
2.   Adaptive  relaxation 
Receptive  relaxation occurs  immediately  after  food intake  when 
gastric fundus  relaxes  to  increase  gastric  volume  whereas  adaptive 
relaxation occurs a while later and is characterized by sustained relaxation 
of  proximal  stomach. 
DISTAL  STOMACH-THE PUMP 
Fundus of stomach  contracts and  pushes  the  food  into  corpus  
and antrum. Here, milling or trituration begins whereby food is grinded  
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into smaller particles of size 1-2mm, the chyme. The  period  from  intake  
till  gastric emptying  into  duodenum is called the lag phase. Then, linear  
phase of gastric emptying  begins when  peristalsis occurs every 20 
seconds and empties  3-4ml of  chyme. 
RESISTANCE TO GASTRIC  EMPTYING 
Resistance to gastric emptying of chyme into duodenum is  
provided by pylorus which modulates resistance as a function of  diameter 
change and also by duodenum. This allows delivery of  nutrients   from 
stomach to duodenum at a rate which is ideal  for  nutrient absorption. 
This mechanism is called as                    antropyloroduodenal coordination. 
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FIGURE4:  SPECTRUM  OF  WORK  IN  GASTRIC  EMPTYING  
OF  SOLID MEAL 
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GASTRIC  EMPTYING  OF  LIQUID  MEAL 
Significant  differences  exist between  gastric  emptying  of  liquid  
meal in  contrast  to  solid  meal, and  include  
1.   Fundus, body, antrum relax nearly simultaneously  to  
accommodate larger  quantities   of  liquid.  
2.  Emptying occurs at a rapid rate than solids.  
3.   Non caloric  liquids  empty  without  lag phase. 
TESTS  IN ASSESSMENT  OF  GASTRIC EMPTYING  
INCLUDING SCINTIGRAPHY 
Gastric emptying of chyme is the most important  mechanical 
function of the  stomach. It  has fascinated  researchers  similar  to cardiac  
ejection of  blood.The history of assessment of gastric emptying is  as  
fascinating  as the process itself. Direct  observation  of  gastric  contents  
across  a fistula.32 aspiration methods to study  gastric  contents, use  of  
pH devices, isotope breath  tests  have  all been tried in the past to 
evaluate  gastric  emptying. But,the modality that attracted  most  
attention has  been  imaging  methods which  allows  direct  visualization  
of  passage  of  gastric  contents from the stomach into the intestines. 
Walter B Cannon  was  a pioneer  in this  regard, his  animal studies  
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involved administration of radioopaque contrast  and  use of fluoroscopic 
imaging  to  visualize   gastric  emptying  of  the  contrast.33 This  was not  
a  practical method  that  can be applied in humans  since  it involved  
considerable  radiation  exposure.  
Barium pellets incorporated into solid meal and use of  serial  
abdominal xrays to analyze  gastric  transit  have  also been tried, but the  
size and  nature of  the  pellets allows it to be emptied  only  during return  
of inter-digestive  migrating  motor  complex and  not  during  emptying  
of chyme.34 In recent times, gastric scintigraphy has emerged as the  most  
widely  used  imaging  modality  in the assessment  of   gastric  emptying. 
It was  introduced  in  1966, in  a pioneering work  by  a group of  
investigators 35 who used  chromium 51 as  a radiolabel  to assess  gastric 
emptying  of  meal. This  study  had  potential   error  due to   early  label 
decay and adherence of label  to stomach lining  long after  food  passed  
into  intestines.  
Then  a specific  solid  label  was developed  in  1976  when 99m 
technetium was  injected  into live chickens, getting  incorporated  into 
liver. After  slaughter  liver  was cooked and  used  as  solid phase label.36 
Solid  phase labeling  became  simpler when 99m technetium  was  
incorporated  into the  colloid  matrix  of scrambled  eggs 37 
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Initial  studies  used  both  solid phase  and liquid  phase  labeling  
using   dual isotopes to study  emptying  of  each. But, it became  clear  
with  further  studies that  liquid  phase  emptying  is grossly  different  
from  solid phase  emptying  in that  liquids do not require   trituration  
unlike  solids and  also that liquid  phase  emptying becomes  abnormal  
only  when  gastroparesis is severe. Thus, solid phase emptying  alone  
came to be studied  in subsequent  studies with  use  of  single  label.After  
radiolabeling the solid meal, the gastric counts  measured by  scintigraphy  
correlate  directly  with the volume of meal retained  in stomach  without   
the  need for  geometric assumptions about  shape of stomach. 
FACTORS TO BE CONSIDERED  IN  MEASUREMENT   OF  
GASTRIC  EMPTYING PATIENT  RELATED  FACTORS  
The  three  important  patient  related factors  to be  considered  in  
measurement of GE include medications, tobacco smoking, 
hyperglycemia. Medications that  affect  gastric motility  such  as 
prokinetics  or opioids need  to discontinue  drug therapy for atleast     48-
72 hours prior  to test. Tobacco smoking  has been shown  to  delay  
gastric  emptying  in prior studies38 It  has been  recommended  that  
patients  refrain  from smoking  on the  morning  of  the test  and  also 
during  the performance of test. Hyperglycemia39  can delay  gastric  
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emptying and  therefore patient  serum  glucose level  must  be  
controlled to values  of  180-275mg/dL  prior to  test, this  being achieved  
with use  of Insulin on the day of  study. 
TECHNICAL FACTORS 
(A) OPTIMAL MEAL 
Meals  currently  used  for  gastric  emptying studies include 
chicken liver, eggs, oatmeals, pancakes. The  content  of  meal is the most 
important factor that requires standardization and guidelines40 
recommend  low fat, egg based meal  as the reference  standard. The  
technetium 99m –sulfur colloid egg meal  consists  of  equivalent  of  two 
large  eggs, two slices  of  bread (120Kcal) and  strawberry  jam (30g,74 
Kcal), water (120ml) ,0.5-1mci of  Tc99m - sulfur colloid. technetium  
has  affinity  for  the  protein matrix of egg white and  gives good  quality  
images. 
(B)   IMAGE  ACQUSITION  
The  radiolabeled meal  must be ingested quickly  within  10 min. 
Images  have  to be  obtained  in  64 x 64  pixel  format  using  a general  
purpose  collimator. A 128x128 word mode  image  matrix  is used. The  
photopeak  settings  are 20%  at the 140ke V peak  of technetium 99m. 
Anterior  and  posterior  planar images  with  distal esophagus, stomach 
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and proximal  small intestine in  the  field  of  view  must  be obtained for   
a period  of  1 min after meal ingestion. 
 
FIGURE5 : IMAGE  OF  GE  MILLENIUM  MPR SPECT  
GAMMA CAMERA 
(C)   OPTIMAL  IMAGING  TIMES  
A  multinational study  established  the  optimal  imaging  points, 
normal values for  gastric  emptying 41 The  study  enrolled  123 normal  
subjects  from 11  medical  institutions in USA, Canada, Europe   and  
imaging was done at 0,1,2,4 hours after ingestion of   radiolabeled  meal. 
This  study  established the  normal  control values  for gastric emptying  
time  as  ULN-upperlimits of  normal(95th percentile).Delayed  gastric  
emptying  was  defined  as  >90%  retention  at 1 hour, > 60%  retention  
at  2 hours,  >10%  retention  at 4 hours. This  study  is by  far  the largest 
published  database of standardized gastric emptying  protocol.  Imaging  
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at 4 hours  after meal  intake  is  critical since  a patient  with normal  
emptying at 2 hours , may  show delayed emptying at 4 hours  and vice 
versa.  
   
 
FIGURE 6 : OPTIMAL TIME POINTS IN IMAGING 
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FIGURE 7 : SOLID PHASE GASTRIC EMPTYING CURVE IN 
NORMAL INDIVIDUALS 
(D)  IMAGE  ANALYSIS TO QUANTIFY GASTRIC  
EMPTYING 
Irregular ROI-Region of interest tool is used  to  draw  an outline 
of stomach .Manual ROI  are  drawn on the  anterior  and  posterior  
images. The  total  gastric  ROI  must  include  fundus  and  antrum, with 
attention to  avoid  small intestinal  loops. The geometric mean(GM) of   
anterior  and  posterior  gastric  counts is calculated   at  each  time  point 
and  may  be  corrected  for  decay  of  99m Tc. GM=(Anterior counts x 
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Posterior  counts)1/2. The  final result is expressed as percent  remaining  
in stomach  at  each  time  point . 
(E)  ASSESSMENT OF  REGIONAL GASTRIC EMPTYING: 
FUNDUS  VERSUS  ANTRAL  RETENTION 
Regional  gastric  emptying  analysis  is  helpful  in understanding 
pathophysiology  related  to dyspeptic  symptoms.  Fundal versus antral  
retention of food can be assessed  by gastric scintigraphy by applying  
irregular  ROI tool. Fundal  retention of food has been  associated  with  
early satiety  whereas antral retention  of  food  has been  associated  with 
vomiting .  
 
(F)  GRADING  OF  GASTROPARESIS40  
 
TABLE  2 
GASTROPARESIS  GRADE PERCENT  RETENTION  
AT  4HOUR 
MILD 11-20 
MODERATE 21-35 
SEVERE 36-50 
VERY  SEVERE >50 
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(G)  SYMPTOM  ANALYSIS  DURING  PERFORMANCE OF  
GASTRIC EMPTYING  TEST 
Monitoring of symptoms of gastroparesis after ingestion of  
radiolabeled meal may help to correlate clinical  symptoms with  
objective assessment of delayed gastric emptying. Symptoms of   
gastroparesis may  be quantified  by a validated  questionnaire  ,the  
GCSI-gastroparesis cardinal symptom  index. It  is  based  on three  
scales  namely  early  satiety, abdominal  bloating,vomiting.42 The  Total  
Score  of   GCSI  ranged from 0-5 and it takes into  account  the total  of   
9 subscales derived from  aforesaid  3 scales. 
TABLE 3: GASTROPARESIS   CARDINAL   SYMPTOM   INDEX    
SUBSCALES 
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MATERIALS AND METHODS 
 
The  study  was  conducted  at  Department  of  Medical 
Gastroenterology Rajiv Gandhi Government  General  Hospital-Chennai 
and  Advanced Nuclear Medicine  Research Institute-Chennai from Feb 
2012 to Feb 2013 .In  all patients history  was taken and physical 
examination done. Then they underwent  baseline investigations 
including  complete blood count, fasting  and post prandial blood sugar, 
renal function test, ultrasound abdomen, upper gastrointestinal endoscopy 
with grading of esophagitis when present, biopsy  of lower esophagus 
was taken if  showing  severe esophagitis or suspicious  for baretts 
esophagus. Two patients  had  already  undergone 24h ambulatory pH   
monitoring as part  of  evaluation  outside. GERD  was  diagnosed  by  
symptomatic criteria – montreal definition(28/28), with  the  predominant 
symptoms being heartburn, regurgitation, endoscopic criteria-LA 
classification (3/28), biopsy  criteria (2/28),24hpH criteria /Demeester 
scoring (2/28). 
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TABLE  4: LOS  ANGELES  CLASSIFICATION  FOR  GRADING  
ESOPHAGITIS 5 
GRADE DESCRIPTION 
A One  or  more mucosal breaks confined 
to folds and < 5mm 
B One  or  more mucosal breaks  confined 
to  folds  > 5mm 
C Mucosal  breaks  continuous between 
top of two mucosal folds  but not 
circumferential 
D circumferential  mucosal breaks 
 
 
FIGURE 8 : LOS ANGELES  CLASSIFICATION  FOR GRADING 
ESOPHAGITIS 
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24h pH  SCORING-DEMEESTER  SCORE  
Components 
1   Upright  reflux 
2   Supine  reflux 
3   Total  reflux 
4   Number  of  episodes 
5   Number  of  episodes  longer  than 5 min 
6   Longest  episode 
     Score  > 14.7 is significant for  reflux 
BIOPSY CRITERIA  
GERD was diagnosed if 
1  Basal cell hyperplasia 
2  Increased  height  of   rete pegs         were  present 
 
All patients  were selected  to undergo  gastric  scintigraphy after  
application of specific inclusion and exclusion criteria. A written informed  
consent was  taken  from  each patient  after  explaining  that  the  
procedure may take  a  time of 4 hours  with need for  intermittent  scans, 
need to eat egg, enquiring  regarding egg allergy, and  radiation exposure. 
Patients who preferred vegetarian diet were given alternative test meal of 
idly and sambhar equivalent to 250Kcal labeled with technetium. 
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Inclusion Criteria  
Age group : 18 -60 years 
Typical  symptoms  of  GERD 
Exclusion  Criteria 
1  Peptic  stricture of  esophagus 
2  Esophageal or gastric  malignancy 
3  Prior history  of  antireflux  or  gastric  surgery 
4  Pregnancy 
5  Severe  cardiorespiratory  illness 
6  Renal  failure 
7  Diabetes mellitus 
GASTRIC  SCINTIGRAPHY  PROCEDURE 
Gastric  Scintigraphy  was done using standard scintigraphic 
protocol.41All patients were on overnight fast and as per prior instructions  
were  advised to stop agents that  may interfere with  gastric motility  
such as prokinetics, opioids, erythromycin for  2 days prior  to the test. 
TEST  MEAL  INTAKE 
All patients were instructed  to take  99m technetium sulfur colloid  
labeled low fat  egg meal with  two slices of bread and jam  (0.5-1 mci Tc 
/255 Kcal). The  meal  was  prepared by  cooking  egg  as  omelette  with  
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incorporation of technetium sulfur colloid(0.5-1mci)  into omelette. Then 
a bread omelette sandwich was made with adding  of jam (30g-strawberry 
flavor) over  the bread. Patients were advised  to take  the meal  within 10 
minutes and serial imaging begun. Two patients who preferred  vegetarian  
meal were  given two idlis(small size with a cup  of sambar with total  
calories equivalent to 250Kcal) labeled with technetium sulfur  
colloid(0.5-1mci) 
SERIAL IMAGING 
Patients then underwent serial imaging with GE  Millennium MPR  
SPECT gamma camera  at 0 min,60 min,120 min,180 min, 240min  after 
test  meal intake  Images were  obtained  in a  format  of 64 x 64 pixels 
using a general purpose collimator with photopeak  settings  being  20%  
at 120 keV for  99m Tc. Images were  obtained  in  same position in  each 
patient,  with  sitting position  being  preferred. The patients position 
remained constant  during  entire study. 
IMAGE  ANALYSIS 
Assessment  of Global Gastric Emptying 
After imaging, analysis for gastric retention done by applying  
irregular region of interest tool (ROI) over  entire stomach, including  
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proximal and  distal stomach as a whole  with  careful  exclusion of  
intestinal loops. 
Assessment of Regional Gastric Emptying 
For assessment of regional gastric emptying, irregular ROI (Region 
of Interest) tool was applied over  proximal  and  distal  stomach  
separately. ROI are drawn on 0 min and 240 min images. Regional gastric 
emptying  includes separate  ROI for  antrum  and fundus of stomach. 
Gastric counts of tracer activity  at  240 min  divided by  gastric counts of  
tracer activity at 0 minutes and expressed as percentage gives  percentage 
retention of  food at  240min. Gastroparesis was considered significant  at 
gastric retention value of  >10 %  at  240 min. 240 minute value was 
taken  for  assessment  of  gastroparesis. 
GRADING OF GASTROPARESIS 
Gastroparesis  was  graded  based on  240 min value  as  
Mild    :  11-20 %  
Moderate  :  21-35 % 
Severe  :  36-50% 
Very  Severe : >50% 
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Regional gastric retention also was expressed  as percentage of 
initial counts remaining in fundus, antrum after  drawing  specific ROI . 
GCSI  -GASTROPARESIS  CARDINAL SYMPTOM  INDEX  
Gastroparesis cardinal symptom index(GCSI) was assessed after  
ingestion of test meal as presence of post prandial fullness,  
nausea/vomiting, abdominal bloating. It was considered significant  when 
2 out of 3 symptoms were positive. The subscales were not analyzed 
separately. Statistical  Analysis  was then done  using  Fisher  Exact  Chi 
Square test, Binomial test (SPSS VERSION 17.0).  
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RESULTS 
 
1. AGE DISTRIBUTION AND SYMPTOMATIC  PERIOD OF  
GERD  CASES 
  This Study included a total of   28 cases 
 
TABLE 5 
Variable Age (years) 
Symptomatic 
Period (Months) 
Number 28 28 
Mean 34.57 20.36 
Median 35.00 12.00 
Std. Deviation 8.846 25.519 
Minimum 19 3 
Maximum 53 120 
 
 
 
FIGURE 9 : AGE DISTRIBUTION 
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2. GENDER  DISTRIBUTION 
[ 
This study  had equal  representation  of  males  and females 
 
 
 
TABLE 6   
Gender Frequency Percentage 
Male 14 50.0 
Female 14 50.0 
Total 28 100.0 
 
 
 
 
 
FIGURE 10 :GENDER  DISTRIBUTION 
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3. GERD  DIAGNOSIS BY  DIFFERENT  CRITERIAE 
All  patients  enrolled   in the  study  had  symptomatic  criteria 
fulfilled(100%). In addition 5 cases had endoscopic evidence of    
esophagitis(17.9%), 2  cases  had  biopsy  evidence of GERD as per 
defined  criteria(7.1%),2 cases who had undergone 24hour pH  study  
were  diagnosed  to have   GERD(7.1%).Of these two patients  one had  
severe alkaline  reflux with demeester pH score of 35 and  another  
patient  had  severe  acid  reflux  with  demeester  pH score   of   34.4 
TABLE 7  : GERD AND OGD 
GERD and OGD Frequency Percentage 
NO 23 82 
YES 5 18 
Total 28 100.0 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
FIGURE 11: ENDOSCOPIC  ESOPHAGITIS  PREVALENCE 
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TABLE 8  : GERD  AND  BIOPSY 
 
GERD and 
Biopsy Frequency Percentage 
NO 26 92.9 
YES 2 7.1 
Total 28 100.0 
  
 
 
 
 
FIGURE 12:  GERD  AND BIOPSY 
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TABLE 9 : GERD  AND  24 HOUR pH STUDY 
  
GERD and pH study Frequency Percent 
NO 26 92.9 
YES 2 7.1 
Total 28 100.0 
 
 
 
 
FIGURE 13 : GERD  AND 24 HOUR pH STUDY 
 
  42
4.  UPPER GI  ENDOSCOPY  FINDINGS  IN ALL PATIENTS: 
57.1% had normal endoscopy and rest of patients had 
abnormalities. Two patients  had  suspicious nodules in distal esophagus 
which were  biopsied. Biopsy  showed histological features  of  GERD 
but no evidence  of  metaplasia  or  dysplasia. Hiatus hernia  was  present  
in  three cases (prevalence 10.7%) and one  of  those patients  had  
Cameron  ulcer  and  Schatzki  B  ring  which  is  considered to be  form 
fruste of  GERD. 
TABLE 10 :  UPPER GI  ENDOSCOPIC FINDINGS IN                      
ALL CASES 
 
OGD Frequency Percent 
Normal 16 57.1 
Losangeles – grade A/C 3 10.7 
Pangastritis 3 10.7 
Antral gastritis 1 3.6 
Nodule in distal esophagus- 
Biopsy taken 
2 7.1 
Hiatus  hernia 2 7.1 
Hiatus hernia/cameron ulcer/ 
schatzki b ring 
1 3.6 
Total 28 100.0 
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FIGURE 14 :UPPER GI  ENDOSCOPIC FINDINGS IN  ALL 
CASES                                
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5. PPI  USE 
Patients were  already  on PPI  in  53.6%   and  rest  were   on  
antacids, H2 receptor antagonists  like tablet ranitidine 150mg b.d These  
patients were  advised to take  PPI  since their  enrollment into study. 
TABLE 11 : PPI  USE  IN ALL CASES 
 
PPI USE Frequency Percent 
  NO 13 46.4 
  YES 15 53.6 
  Total 28 100.0 
 
 
 
FIGURE 15 : PPI USE IN ALL CASES 
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6.  PPI  SENSITIVITY 
96.4% of patients were sensitive to PPI. Only one patient 
demonstrated to have severe alkaline reflux on 24h pH study, had 
heartburn refractory to  PPI therapy. He  also had  positive  gastroparesis 
cardinal symptom index. 
 
 TABLE  12 : PPI  SENSITIVITY PREVALENCE 
PPI Sensitive Cases Frequency Percent 
YES 27 96.4 
NO 1 3.6 
Total 28 100.0 
 
 
 
 
FIGURE 16  :  PPI SENSITIVITY PREVALENCE 
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7.  GASTROPARESIS  PREVALENCE  
Gastroparesis was noted to have a prevalence of 10.7% (being 
positive  in three out  of  twenty  eight  cases) 
TABLE  13 : PREVALENCE OF GASTROPARESIS 
 
Gastroparesis Frequency Percentage 
 Negative 25 89.3 
 Positive 3 10.7 
 Total 28 100.0 
 
  
 
 
FIGURE 17 : PREVALENCE  OF  GASTROPARESIS 
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8.  INDIVIDUAL  ANALYSIS  OF  DELAYED  GASTRIC  
EMPTYING  IN  THREE  PATIENTS 
 
GRADE OF GASTROPARESIS 
All three patients   who were  found  to have  gastroparesis had 
mild  gastroparesis  as  per  grading  of  gastroparesis. 
 
TABLE 14  
 
% Retention at 4 H Frequency Percent 
10.16 1 3.6 
11.60 1 3.6 
12.60 1 3.6 
Total 3 10.7 
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FUNDAL VERSUS ANTRAL RETENTION OF  MEAL 
Out  of   three  patients  who  had  gastroparesis, fundal retention  
predominated  in  two cases  and  antral retention predominated  in  one  
case. 
TABLE  15  
 
Case Fundal Retention 
(%) 
Antral Retention 
(%) 
1 5.72 4.44 
2 5.60 7.04 
3 7.9 3.7 
 
 
 
FIGURE  18 : FUNDAL VERSUS  ANTRAL RETENTION 
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9. GASTROPARESIS  CARDINAL SYMPTOM INDEX:( GCSI ) 
Gastroparesis Cardinal Symptom Index was  positive in 5 cases 
(17.9%) and  negative  in 82.1 % cases. All patients  who had positive  
GCSI had early satiety  and abdominal bloating  as symptoms.None  
presented with vomiting  of  test  meal. 
 
TABLE 16  :  GCSI  DURING  SCINTIGRAPHY 
 
 
 
FIGURE 19 : GCSI   DURING  SCINTIGRAPHY 
 
GCSI Frequency Percentage 
 NEGATIVE 23 82.1 
 POSITIVE 5 17.9 
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10.  GENDER DIFFERENCE IN PREVALENCE OF 
GASTROPARESIS 
Of the three patients  with gastroparesis,two were females  and one 
was male  (66.7%  versus 33.3%) 
 
 
 
 
FIGURE 20: GENDER DIFFERENCE IN PREVALENCE OF  
GASTROPARESIS 
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11  CORRELATION BETWEEN  GCSI  AND GASTROPARESIS 
GCSI was positive in  five out  of  28 cases whereas  gastroparesis 
was  present   in only three  out of   28 cases.Statistical  analysis  revealed 
lack of  significant  correlation  between  GCSI  and gastroparesis. 
 
TABLE 17 : CORRELATION  BETWEEN  GCSI  AND 
GASTROPARESIS 
GPSI during SCINTI * GP± Crosstabulation 
   GP± 
Total Negative Positive 
GPSI 
during 
SCINTI 
Negative Count 22 1 23
% within GP± 88.0% 33.3% 82.1%
Positive Count 3 2 5
% within GP± 12.0% 66.7% 17.9%
Total Count 25 3 28
% within GP± 100.0% 100.0% 100.0%
 
P value  for  correlation is  0.073 (NS,Fishers Exact  Test) and  is 
not significant   indicating  a poor  correlation between  GCSI  and 
objective  evidence  of   gastroparesis. 
12  PREVALENCE  OF  GASTROPARESIS:SIGNIFICANCE 
 Based on the  binomial test(p=0.5),the  prevalence of  gastroparesis 
(10.7%)  is significant   at p <0.005 
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FIG 21(a) NORMAL DISTAL ESOPHAGUS 
 
 
 
 
 
 
FIG 21(b) DISTAL ESOPHAGITIS –GRADE C 
(LA CLASSIFICATION) 
 
 
 
 
 
 
 
 
FIG 21(c) LAX LES IN HIATUS HERNIA 
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FIGURE 22 GERD AND BIOPSY 
 
This  biopsy   taken from nodule in distal esophagus shows  
features  of  squamous  epithelium  with  basal cell hyperplasia  
suggestive  of  GERD 
LOW POWER VIEW                               
 
 
 
 
 
 
 
 
 
HIGH POWER VIEW 
                                                                            XX 
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FIGURE  23 :NORMAL  GASTRIC  EMPTYING  ( AT  4 HOURS) 
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FIGURE 24: GASTROPARESIS CASE 1 
 
  56
 
 
 
FIGURE 25:GASTROPARESIS CASE 2 
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FIGURE 26: GASTROPARESIS CASE  3 
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DISCUSSION 
 
Typical office cohort of GERD patients may present with 
symptoms heart burn  and regurgitation, but may have additional  
symptoms of postprandial fullness, nausea, abdominal bloating. 
Alternatively, patients may also present as nonresponders to proton  
pump  therapy. This  group  of  patients  represent  overlap  cases  with  
functional  dyspepsia and  usually  account  for   one third  of  all  GERD 
cases.6 The diagnosis of  such overlap  cases  requires high index  of  
suspicion  since all  symptoms may be attributed to GERD  alone. Once  
the  diagnosis of  such overlap is entertained, further testing is  mandatory  
to confirm  the  suspicion .It  is  imperative to  rule  out organic causes of  
dyspepsia by  performing  upper gastrointestinal endoscopy. Screening  
endoscopy can also help categorize GERD into anyone of three  
categories  namely  erosive, nonerosive, complicated GERD. Biopsies  as  
required  for  suspected  barretts, may  be  essential  but Schindlebeck NE 
et al have  shown that  there is  no role  for  routine  biopsy of  lower 
esophagus  in uncomplicated  GERD43  24h  ambulatory  pH  monitoring  
is  also  important  in  diagnostic  workup  as  it  is  the  current standard 
for diagnosis of GERD (including NERD). Also, Noh Y et al have shown 
significant association between NERD and functional dyspeptic  
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symptoms18. Once GERD  is  categorized into aforesaid categories, next 
step in uncomplicated cases would be a gastric  emptying  study since 
gastric emptying abnormalities are known to  occur in patients  with such 
overlap  features. In particular, Gonlachanvit et al have shown in their 
seminal  study  that  delayed  gastric  emptying  and antral retention of 
test meal occur  in  cases  of  functional  dyspepsia20. Gastric emptying  
may  be studied  by group of  tests  including gastric scintigraphy, 
functional ultrasonography, MRI. Marzio L et al have shown that 
functional  ultrasound  is  useful  mainly  in  assessment of  liquid phase 
emptying  study  and that  liquid emptying does not become abnormal  till 
gastroparesis  is  severe.11. Functional  ultrasound  requires  assumptions 
to be  made  regarding  geometric  shape  of  stomach  and  therefore may 
not  be very  accurate  as a  study  for  gastric emptying. MRI is  evolving 
in assessment  of   gastric  emptying  and  is  also expensive. 
Gastric  scintigraphy  for  assessment  of  gastric  emptying  ,which 
came  into  clinical  application  since  1966,has  evolved  over  past forty  
seven years to be considered  the  current  gold  standard. The advantages  
of   scintigraphy  include  availability  of  international standard  values  
for  normal  gastric  emptying  derived from the seminal study by  Tougas 
et al41 and  that  it  can  help  assess  gastroparesis as  a dysfunction  of  
whole stomach, fundus, antrum.This  helps  us  to  understand  the  
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pathophysiology  of  functional  dyspepsia  in  a  better  way, so  that  it  
may guide us to optimize  therapy. Our study  shows  that  the  prevalence  
of idiopathic  gastroparesis  in   uncomplicated, office  cohort of  GERD  
cases to be  10.7%  as  against   prevalence of  25% shown by Koch KL  
et al7 This variable prevalence has been attributed  to  differences in study 
methodology, variable patient  selection  criteria  and  inclusion  of  
patients  with  diabetes  mellitus, a known  risk  factor  for  gastroparesis. 
 
The study done by Gonlachanvit et al had assessed gastric  
emptying in overlap  cases and  found  that  gastric  emptying is   delayed 
in 50% of overlap  cases 20.They  also report  that  distal  gastric retention  
was  prominent  in  overlap  cases in  contrast to  GERD   cases  alone. In 
contrast, our study results show predominance of fundal retention of food 
in overlap cases.  
 
Gastroparesis cardinal symptom index is a questionnaire applicable 
in patients with gastroparesis. This symptom complex  questionnaire  has 
three scales and  nine subscales. Our study  aimed to apply this  
questionnaire  in  all  subjects, in  the immediate postprandial period after 
ingestion of   technetium labeled  meal, since it was an ideal  time to 
observe  the   symptoms  and  correlate it  with  occurrence  of  delayed   
gastric  emptying. Interestingly, five  patients  satisfied  two out of three  
scales of  gastroparesis index within  30min  after  ingestion of  test meal 
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but only two of them had objective evidence of   gastroparesis. Statistical   
analysis  of   the same   revealed  only  modest  correlation    between 
GCSI and scintigraphic demonstration of gastroparesis (p=0.073 Fischer 
Exact Test). This   observation  has  important  implications. Despite 
noting that patients had   symptoms  suggestive  of gastroparesis, 
scintigraphy could  not  demonstrate  delayed  gastric  emptying  in  three 
out  of five  patients  who   were  positive  for   symptom index. Since  we  
know that  scintigraphy is a sensitive  tool  for  detection of gastroparesis, 
the  role of  other   pathophysiological  factors  such  as  visceral  
hypersensitivity, altered  gut neurotransmission  may  explain  symptoms 
in such  patients. Also, the lack of correlation between GCSI and 
gastroparesis mandates need for gastric scintigraphy to objectively rule in 
or rule out gastroparesis. 
All  three  cases  of  gastroparesis  seen in our study were only of 
mild grade (10 – 20 % retention). This  is  in  concordance  with study 
done by Sarnelli et al  which  evaluated  gastric  emptying in  GERD  
cases.25 
Also, in our study ,gastroparesis  was  diagnosed  in  two  females  
and  one male (66.7vs33.3%) This  female preponderance of   
gastroparesis  has  been  noted by  Soykan I et al  who  demonstrated  
gastroparesis with  82%  prevalence  in  females  compared  to   18%  in 
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males. 44 Indeed Gill RC et al demonstrated delayed  gastric  emptying  in  
females  especially  during  luteal  phase of  menstrual cycle 45 In contrast, 
a study done by Walsh  J W et al that  tried  to  correlate gastroparesis 
with estrogen, progesterone values had not found significant correlation46. 
In our study, one  patient  had  PPI  nonresponsiveness(3.6% 
prevalence).This patient  was  initially responsive  to  PPI  for  a period  
of  2 years,then he  had  become   gradually nonresponsive  to  PPI. This  
patient  developed  positive  GCSI  immediately after   ingestion of   test 
meal and  objective  evidence  of   gastroparesis(11.6%)with  fundal  
predominance  of  meal retention. Interestingly  the  patient had 
ambulatory  pH  evidence  of   severe  alkaline  reflux  with  pH  score of 
35.This  patient  was treated  with  PPI and prokinetics (T.Domperidone  
10mg b.d) . He had partial  symptom  improvement.The  therapeutic  
impact  of  diagnosing  gastroparesis in patients  with  GERD  thus  has  
two caveats.First,gastroparesis  may impair  treatment  efficacy  of  PPIs. 
Delay  in gastric emptying  of  premeal  PPI  may  affect  its delivery  to  
effector  site, namely  the proton pumps   at   appropriate time  and thus  
impair  its  efficacy. Thus, PPI  formulations  that  may  release  the  drug  
faster  than normal may  be  indicated in such cases. Two  formulations 
tried include omeprazole immediate release  tablets given reconstituted  
with water and  lansoprazole  oral  dissolving  formulation.47 This  may 
help overcome PPI  nonresponsiveness. Secondly, prokinetics and drugs 
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useful in management  of  functional dyspepsia  such as acotiamide, 
buspirone  may have role in  management  of  patients  with  
gastroparesis. Prokinetics  tried in past  have been limited by  side effects 
,none more than the ideal  prokinetic cisapride which was  removed from 
market  in view of  propensity  to  cause cardiac  dysrhythmias.The  drug  
which has captured recent  attention is acotiamide which  acts by  dual  
mechanism of  inhibition of   muscarinic autoreceptors in enteric nervous  
system and also by inhibition  of acetylcholinesterase  thereby  
augmenting  parasympathetic  transmission. 
Phase III trials of the  drug at a dose of 100mg t.i.d for 4 weeks 
have shown  good  response  in functional dyspepsia patients   with few 
side effects,including  hypertriglyceridemia48Further  studies  are needed 
to incorporate  this drug into  routine clinical practice.Thus  it is  very 
clear that diagnosis  of  gastroparesis using gastric scintigraphy  in GERD 
cases presenting   with FD overlap is mandatory  to help guide further 
therapy  in this group  of  patients who may not  be  PPI  responsive in the 
long run. 
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CONCLUSIONS 
 
1   There is a significant  prevalence of gastroparesis  in gastroesophageal  
reflux  disease (10.7%). 
2   All cases  of  gastroparesis  detected in GERD patients  were of mild 
grade. 
3   Fundal retention  predominated  over  antral  retention  in cases with  
gastroparesis (66.7% versus 33.3% ). 
4   Gastroparesis  was  found  predominantly  in female patients (66.7%  
vs33.3%). 
5   The  Correlation  between   gastroparesis  Cardinal symptom  index  
and  scintigraphic  gastroparesis  was  not  significant. 
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GLOSSARY / ACRONYMS 
 
GERD  :  GASTRO ESOPHAGEAL REFLUX DISEASE 
LES :  LOWER ESOPHAGEAL SPHINCTER 
TLOSR :  TRANSIENT LOWER ESOPHAGEAL 
SPHINCTER RELAXATIONS 
GE :  GASTRIC EMPTYING 
ROI :  REGION OF INTEREST 
GCSI :  GASTROPARESIS CARDINAL SYMPTOM 
INDEX 
FD :  FUNCTIONAL DYSPEPSIA 
PPI :  PROTON PUMP INHIBITOR 
GPCR :  G PROTEIN COUPLED RECEPTOR 
ICC :  INTERSTITIAL CELLS OF CAJAL 
GM :  GEOMETRIC MEAN 
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INFORMED CONSENT FORM 
 
Title of the Study 
Gastroparesis in Gastroesophageal reflux disease-prevalence and 
assessment using gastric scintigraphy 
Name of the Participant: 
_______________________________________  
 
Name of the Investigator  :  Dr. Arvind . M.A 
 
Name of the Institution   :    Madras Medical College. 
 
Documentation of the informed consent 
 
I _________________________  have read the information of this 
form (or it had been read to me). I was free to ask any questions and they 
have been answered. I  hereby give my consent to be included as a 
participant in Gastroparesis in Gastroesophageal reflux disease-
prevalence and assessment using gastric scintigraphy 
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1.  I have read and understood this consent form and the information 
provided to me. 
2. I have had the consent document explained to me. 
3. I have been explained about the nature of the study. 
4. I have been explained about my rights and responsibilities by the 
investigator.  
Name and signature / thump impression of the participant 
Name _____________________ Signature _____________ Date____ 
 
Name and signature of impartial witness (required for illiterate patients): 
Name _____________________ Signature _____________ Date____ 
 
Address and contact number of the impartial witness: 
 
Name and signature of the investigator or his representative obtaining 
consent: 
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GASTROPARESIS IN GERD-PREVALENCE AND ASSESSMENT 
USING  GASTRIC SCINTIGRAPHY-PROFORMA 
Name 
 
  
GE No 
 
  
Age 
 
  
Gender 
 
  
Address 
 
  
Diagnosis 
 
  
Phone Number 
 
  
Date 
 
  
History Heart burn  
 
Nausea/Vomiting 
 
Post cibal fullness 
 
Alarm symptoms 
 
Drug history 
 
Pregnancy 
 
History of antireflux 
surgery 
 
History of gastric surgery 
 
History of diabetes 
 
Any co morbid illness 
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Examination Vital signs 
 
General examination 
 
Per abdomen 
 
Other system 
 
 
Investigations 
 
Fasting blood sugar 
 
Post prandial blood sugar 
 
Hemogram 
 
Renal function test 
 
Upper gi endoscopy 
 
Gastric scintigraphy 
 
 
 
Gastric 
scintigraphy 
 
 
 
 
Imaging time 
 
0 h 
 
1h 
 
2h 
 
4h 
 
%RETENTION 
Gastroparesis Present  
  17
 
Absent 
 
If present  
 
Grade  
 
Fundal dysfunction 
 
Antral dysfunction 
 
Vomiting of meal (Y/N) 
 
Any unusual findings 
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Name Age Gender 
SYM 
PERIOD 
PPI 
NAÏVE 
PPI 
REF GERD-S 
GERD
+OGD 
GERD 
+BIOPSY 
GERD 
+24 
HpH OGD GCSI GP 
% RET
AT 4 H 
GRADE
OF GP 
F 
RET 
% 
A 
RET 
% 
Karthik 40 M 1 YEAR YES - YES - - - NORMAL 0 neg 0 - - - 
Dhanasekar 39 M 2 YEARS YES - YES - - - NORMAL 0 neg 0 - - - 
Ganesh Kumar 23 M 6 MONTHS YES - YES YES - - LA grA 0 neg 0 - - - 
Padma  53 F 6 MONTHS - - YES - - - PAN-G 0 neg 0 - - - 
Murugan 26 M 6 MONTHS YES - YES - - - ANTRAL-G 0 neg 0 - - - 
Sumathy 44 F 8 MONTHS YES - YES - - - NORMAL 0 neg 0 - - - 
Solai 28 M 3 YEARS - - YES YES - - LA grA 0 neg 0 - - - 
Rajesh 27 M 1 YEAR - - YES  YES - NODULE-DE 2 neg 0 - - - 
Ruth 35 F 8 MONTHS - - YES - - YES NORMAL 2 pos 12.6 Mild 5.6 7.04 
Suresh 38 M 5 YEARS     YES       
HH/CAMERON
ULCER/ 
SCHATZKI B 0 neg 0 - - - 
Maragadam 26 F 2 YEARS YES   YES       NORMAL 2 neg 0 - - - 
Padma 2 27 F 1 YEAR YES   YES       NORMAL  0 pos 10.16 Mild 5.72 4.4 
Murugan2 40 M 2 YEARS   YES YES     YES HH+ 2 pos 11.6 Mild 7.9 3.7 
Akilandam 35 F 3 YEARS     YES       NORMAL 0 neg 0 - - - 
Stalin 35 M 6 MONTHS     YES       PAN-G 2 neg 0 - - - 
Ananth 23 M 6 MONTHS YES   YES       NORMAL 0 neg 0 - - - 
Srinivasan 33 M 8 MONTHS YES   YES       NORMAL 0 neg 0 - - - 
Uma 27 F 1 YEAR     YES       NORMAL 0 neg 0 - - - 
Gunasekar 47 M 1 YEAR     YES       HH+ 0 neg 0 - - - 
Kalavathy 32 F 1 YEAR YES   YES       NORMAL 0 neg 0 - - - 
Jayanthi 38 F 3 MONTHS YES   YES       PAN-G 0 neg 0 - - - 
Udayakumar 31 M 7 MONTHS YES   YES       NORMAL 0 neg 0 - - - 
Padma 3 50 F 10 YEARS     YES       NORMAL 0 neg 0 - - - 
Vanaja 48 F 6 MONTHS YES   YES       NORMAL 0 neg 0 - - - 
Susila 38 F 6 YEARS     YES  YES   NODULE-DE 0 neg 0 - - - 
Jalendra 26 F 1 YEAR YES   YES       NORMAL 0 neg 0 - - - 
Gopi 40 M  1 YEAR     YES       NORMAL 0 neg 0 - - - 
Narmadha 19 F 8 MONTHS YES   YES YES     LA grC 0 neg 0 - - 0 
MASTER CHART 
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MASTER CHART ABBREVIATION 
 
1.  LA   –  LOS ANGELES 
2.  A   –  ANTRAL 
3.  F   –  FUNDAL 
4.  HH   –  HIATUS HERNIA 
5.  DE   –  DISTAL ESOPHAGUS 
6.  PAN-G  –  PAN GASTRITIS 
7.  ANTRAL G  –  ANTRAL GASTRITIS 
8.  RET   –  RETENTION 
9. SYM  - SYMPTOMATIC 
10. REF  - REFRACTORY 
